Dr. Ann Newman is currently a pharmaceutical consultant at Seventh Street Development Group with over 30 years of large pharma and contract research experience. She provides consulting, training, and webcasts on solid-state issues for pharmaceutical companies. Ann received her PhD in Chemistry from the University of Connecticut. For ten years, she performed characterization studies on a wide range of pharmaceutical systems at Bristol-Myers Squibb, covering drug substance and product scale-up from late drug discovery to launch and manufacturing. She then became Vice President of Materials Science at SSCI, Inc. overseeing characterization of API and drug product samples, crystallization and polymorph screens, salt and cocrystal selections, quantitative assays, amorphous projects, and problem solving for the pharmaceutical industry. As Vice President of Research and Development at Aptuit, she instituted a companywide R&D initiative over six global sites and covering areas such as API, preclinical (toxicology, safety, pharmacokinetics), formulation, solids, analytical, clinical packaging, and regulatory. She holds an adjunct faculty position in Industrial and Physical Pharmacy at Purdue University and is author/collaborator on over 60 publications, 100 technical presentations, and 50 webinars.
Solid-State and Pharmaceutical Consultant
Seventh Street Development Group